Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 1/2010

01.01.2010 | Article

The intracellular effects of manuka honey on Staphylococcus aureus

verfasst von: A. F. Henriques, R. E. Jenkins, N. F. Burton, R. A. Cooper

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to investigate the effect of manuka honey on Staphylococcus aureus in order to identify the intracellular target site. The mode of inhibition of manuka honey against S. aureus NCTC 10017 was investigated by determining the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and the effect of time on viability. Structural changes were observed by scanning (SEM) and transmission electron microscopy (TEM) of cells suspended for 4 h at 37°C in 0.05 mM Tris buffer containing 10% (w/v) manuka honey and were compared to cells in buffer alone or buffer containing 10% (w/v) artificial honey (to assess osmotic damage). A bactericidal mode of inhibition for manuka honey on S. aureus was established. Marked structural changes in honey-treated cells were seen only with TEM, where a statistically significant increase in the number of whole cells with completed septa compared to untreated cells were observed (P < 0.05). Structural changes found with TEM suggest that honey-treated cells had failed to progress normally through the cell cycle and accumulated with fully formed septa at the point of cell division without separating. Sugars were not implicated in this effect. The staphylococcal target site of manuka honey involves the cell division machinery.
Literatur
1.
Zurück zum Zitat Bogdanov S, Ruoff K, Oddo LP (2004) Physico-chemical methods for the characterisation of unifloral honeys: a review. Apidologie 35:S4–S17CrossRef Bogdanov S, Ruoff K, Oddo LP (2004) Physico-chemical methods for the characterisation of unifloral honeys: a review. Apidologie 35:S4–S17CrossRef
2.
Zurück zum Zitat Molan PC (1992) The antibacterial activity of honey. 1. The nature of the antibacterial activity. Bee World 73:5–28 Molan PC (1992) The antibacterial activity of honey. 1. The nature of the antibacterial activity. Bee World 73:5–28
3.
Zurück zum Zitat Cooper RA, Halas E, Molan PC (2002) The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil 23:366–370CrossRefPubMed Cooper RA, Halas E, Molan PC (2002) The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil 23:366–370CrossRefPubMed
4.
Zurück zum Zitat Cooper RA, Molan PC, Harding KG (2002) The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 93:857–863CrossRefPubMed Cooper RA, Molan PC, Harding KG (2002) The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 93:857–863CrossRefPubMed
5.
Zurück zum Zitat Blair SE, Carter DA (2005) The potential for honey in the management of wounds and infection. J Austr Infect Cont 10:24–31 Blair SE, Carter DA (2005) The potential for honey in the management of wounds and infection. J Austr Infect Cont 10:24–31
6.
Zurück zum Zitat Willix DJ, Molan PC, Harfoot CG (1992) A comparison of the sensitivity of wound-infecting species of bacteria to the antibacterial activity of manuka honey and other honey. J Appl Bacteriol 73:388–394PubMed Willix DJ, Molan PC, Harfoot CG (1992) A comparison of the sensitivity of wound-infecting species of bacteria to the antibacterial activity of manuka honey and other honey. J Appl Bacteriol 73:388–394PubMed
7.
8.
Zurück zum Zitat French VM, Cooper RA, Molan PC (2005) The antibacterial activity of honey against coagulase-negative staphylococci. J Antimicrob Chemother 56:228–231CrossRefPubMed French VM, Cooper RA, Molan PC (2005) The antibacterial activity of honey against coagulase-negative staphylococci. J Antimicrob Chemother 56:228–231CrossRefPubMed
9.
Zurück zum Zitat Karayil S, Deshpande SD, Koppikar GV (1998) Effect of honey on multidrug resistant organisms and its synergistic action with three common antibiotics. J Postgrad Med 44:93–96PubMed Karayil S, Deshpande SD, Koppikar GV (1998) Effect of honey on multidrug resistant organisms and its synergistic action with three common antibiotics. J Postgrad Med 44:93–96PubMed
10.
Zurück zum Zitat Natarajan S, Williamson D, Grey J, Harding KG, Cooper RA (2001) Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatolog Treat 12:33–36CrossRefPubMed Natarajan S, Williamson D, Grey J, Harding KG, Cooper RA (2001) Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatolog Treat 12:33–36CrossRefPubMed
11.
12.
Zurück zum Zitat Visavadia BG, Honeysett J, Danford MH (2008) Manuka honey dressing: an effective treatment for chronic wound infections. Br J Oral Maxill Surg 46:55–56CrossRef Visavadia BG, Honeysett J, Danford MH (2008) Manuka honey dressing: an effective treatment for chronic wound infections. Br J Oral Maxill Surg 46:55–56CrossRef
13.
Zurück zum Zitat Blaser G, Santos K, Bode U, Vetter H, Simon A (2007) Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care 16(8):325–328PubMed Blaser G, Santos K, Bode U, Vetter H, Simon A (2007) Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care 16(8):325–328PubMed
14.
Zurück zum Zitat Mavric E, Wittmann S, Barth G, Henle T (2008) Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Foods Res 52(4):483–489CrossRef Mavric E, Wittmann S, Barth G, Henle T (2008) Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Foods Res 52(4):483–489CrossRef
15.
Zurück zum Zitat Adams CJ, Boult CH, Deadman BJ, Farr JM, Grainger MNC, Manley-Harris M, Snow MJ (2008) Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 343(4):651–659CrossRefPubMed Adams CJ, Boult CH, Deadman BJ, Farr JM, Grainger MNC, Manley-Harris M, Snow MJ (2008) Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 343(4):651–659CrossRefPubMed
16.
Zurück zum Zitat Adams CJ, Manley-Harris M, Molan PC (2009) The origin of methylglyoxal in New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 344(8):1050–1053CrossRefPubMed Adams CJ, Manley-Harris M, Molan PC (2009) The origin of methylglyoxal in New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 344(8):1050–1053CrossRefPubMed
17.
Zurück zum Zitat Allen KL, Molan PC, Reid GM (1991) A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 43(12):817–882PubMed Allen KL, Molan PC, Reid GM (1991) A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 43(12):817–882PubMed
18.
Zurück zum Zitat Lemar KM, Turner MP, Lloyd D (2002) Garlic (Allium sativum) as an anti-Candida agent: a comparison of the efficacy of fresh garlic and freeze-dried extracts. J Appl Microbiol 93:398–405CrossRefPubMed Lemar KM, Turner MP, Lloyd D (2002) Garlic (Allium sativum) as an anti-Candida agent: a comparison of the efficacy of fresh garlic and freeze-dried extracts. J Appl Microbiol 93:398–405CrossRefPubMed
19.
Zurück zum Zitat Forrest RD (1982) Early history of wound treatment. J R Soc Med 75(3):198–205PubMed Forrest RD (1982) Early history of wound treatment. J R Soc Med 75(3):198–205PubMed
20.
Zurück zum Zitat Andreoni O, Andreoni S, Molinari GL, Farinetti F (1985) In vitro antibacterial activity of ceftizoxime. Chemioterapia 4(2):161–165PubMed Andreoni O, Andreoni S, Molinari GL, Farinetti F (1985) In vitro antibacterial activity of ceftizoxime. Chemioterapia 4(2):161–165PubMed
21.
Zurück zum Zitat Hugo WB, Longworth AR (1965) Cytological aspects of the mode of action of chlorhexidine diacetate. J Pharm Pharmacol 17:28–32PubMed Hugo WB, Longworth AR (1965) Cytological aspects of the mode of action of chlorhexidine diacetate. J Pharm Pharmacol 17:28–32PubMed
22.
Zurück zum Zitat Schreier H, Erdos G, Reimer K, König B, König W, Fleischer W (1997) Molecular effects of povidone-iodine on relevant microorganisms: an electron-microscopic and biochemical study. Dermatology 195(Suppl 2):111–116CrossRefPubMed Schreier H, Erdos G, Reimer K, König B, König W, Fleischer W (1997) Molecular effects of povidone-iodine on relevant microorganisms: an electron-microscopic and biochemical study. Dermatology 195(Suppl 2):111–116CrossRefPubMed
23.
Zurück zum Zitat Thomas DG, Hann AC, Day MJ, Wilson JM, Russell AD (1999) Structural changes induced by mupirocin in Staphylococcus aureus cells. Int J Antimicrob Agents 13:9–14CrossRefPubMed Thomas DG, Hann AC, Day MJ, Wilson JM, Russell AD (1999) Structural changes induced by mupirocin in Staphylococcus aureus cells. Int J Antimicrob Agents 13:9–14CrossRefPubMed
24.
Zurück zum Zitat Errington J, Daniel RA, Scheffers D-J (2003) Cytokinesis in bacteria. Microbiol Mol Biol Rev 67:52–65CrossRefPubMed Errington J, Daniel RA, Scheffers D-J (2003) Cytokinesis in bacteria. Microbiol Mol Biol Rev 67:52–65CrossRefPubMed
25.
Zurück zum Zitat Blair SE, Cokcetin NN, Harry EJ, Carter DA (2009) The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-009-0763-z PubMed Blair SE, Cokcetin NN, Harry EJ, Carter DA (2009) The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. Eur J Clin Microbiol Infect Dis. doi:10.​1007/​s10096-009-0763-z PubMed
Metadaten
Titel
The intracellular effects of manuka honey on Staphylococcus aureus
verfasst von
A. F. Henriques
R. E. Jenkins
N. F. Burton
R. A. Cooper
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2010
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0817-2

Weitere Artikel der Ausgabe 1/2010

European Journal of Clinical Microbiology & Infectious Diseases 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.